Emerald Acquisition’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Other funds holding ALNY
BFA
BIT
Emerald Acquisition's ALNY Position: Q3 2016 in Review
Emerald Acquisition reduced its Alnylam Pharmaceuticals (ALNY) stake by 54% in Q3 2016, selling an estimated $5.23M and leaving 62,948 shares worth $4.27M. The position accounts for 0.01% of the portfolio, ranked #1297.
Emerald Acquisition first reported a position in ALNY in Q2 2016 and has held it in 2 quarters since. The position peaked at $7.61M in Q2 2016. 258 funds tracked by Wall St. Rank hold ALNY as of Q3 2016.
- Emerald Acquisition held 62,948 shares of Alnylam Pharmaceuticals worth $4.27M as of Q3 2016.
- Emerald Acquisition sold 74,123 Alnylam Pharmaceuticals shares in Q3 2016, an estimated $5.23M.
- Alnylam Pharmaceuticals made up 0.01% of Emerald Acquisition's portfolio in Q3 2016, its #1297 holding.
- Emerald Acquisition first reported a position in Alnylam Pharmaceuticals in Q2 2016 and has held it in 2 quarters since.
- Emerald Acquisition's Alnylam Pharmaceuticals position peaked at $7.61M in Q2 2016.
- 258 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2016.
Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.